| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Strongbridge Biopharma plc | Director | Ordinary Shares | 0 | $2.06 | 05 Oct 2021 | By HealthCap VI, L.P. | |
| Strongbridge Biopharma plc | Director | Stock Option (Right to Buy) | 0 | 05 Oct 2021 | By HealthCap VI, L.P. |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000117911021009280-steen-marten-2021-10-05 | Strongbridge Biopharma plc | 05 Oct 2021 | 2 | $0 | 4 | Director | 06 Oct 2021, 19:41 |
| /report/000117911021009226-steen-marten-2021-10-01 | Strongbridge Biopharma plc | 01 Oct 2021 | 1 | -$36,592 | 4 | Director | 05 Oct 2021, 19:26 |
| /report/000117911021005558-steen-marten-2021-05-18 | Strongbridge Biopharma plc | 18 May 2021 | 1 | $0 | 4 | Director | 18 May 2021, 19:14 |
| /report/000117911021005553-steen-marten-2021-05-14 | Strongbridge Biopharma plc | 14 May 2021 | 1 | -$44,659 | 4 | Director | 18 May 2021, 19:06 |